Evidence map›Paper›PMID 33210453›Full record

ArticleStem cells translational medicine2020

Chromatin accessibility in canine stromal cells and its implications for canine somatic cell reprogramming.

Maria Questa, Maryam Moshref, Robert J Jimenez, Veronica Lopez-Cervantes, Charles K Crawford, Matthew L Settles, Pablo J Ross, Amir Kol

Open access · goldAbstract read
In one paragraph

Article in Stem cells translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Maria QuestaDepartment of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California Davis, Davis, California, USA.ORCID https://orcid.org/0000-0002-3628-5031
Maryam MoshrefDepartment of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California Davis, Davis, California, USA.ORCID https://orcid.org/0000-0001-9146-6751
Robert J JimenezDepartment of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California Davis, Davis, California, USA.
Veronica Lopez-CervantesDepartment of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California Davis, Davis, California, USA.
Charles K CrawfordDepartment of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California Davis, Davis, California, USA.
Matthew L SettlesBioinformatics Core Facility, University of California Davis, Davis, California, USA.
Pablo J RossDepartment of Animal Science, University of California Davis, Davis, California, USA.
Amir KolDepartment of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California Davis, Davis, California, USA.
University of California, Davis · US

Funding

Veterinary Institute for Regenerative Cures, School of Veterinary Medicine, University of California Davis. Center for Companion Animal Health, School of Veterinary Medicine, University of California Davis.
6 · The paper itself

Abstract

Naturally occurring disease in pet dogs is an untapped and unique resource for stem cell-based regenerative medicine translational research, given the many similarities and complexity such disease shares with their human counterparts. Canine-specific regulators of somatic cell reprogramming and pluripotency maintenance are poorly understood. While retroviral delivery of the four Yamanaka factors successfully reprogrammed canine embryonic fibroblasts, adult stromal cells remained resistant to reprogramming in spite of effective viral transduction and transgene expression. We hypothesized that adult stromal cells fail to reprogram due to an epigenetic barrier. Here, we performed assay for transposase-accessible chromatin using sequencing (ATAC-seq) on canine stromal and pluripotent stem cells, analyzing 51 samples in total, and establishing the global landscape of chromatin accessibility before and after reprogramming to induced pluripotent stem cells (iPSC). We also studied adult stromal cells that do not yield iPSC colonies to identify potential reprogramming barriers. ATAC-seq analysis identified distinct cell type clustering patterns and chromatin remodeling during embryonic fibroblast reprogramming. Compared with embryonic fibroblasts, adult stromal cells had a chromatin accessibility landscape that reflects phenotypic differentiation and somatic cell-fate stability. We ultimately identified 76 candidate genes and several transcription factor binding motifs that may be impeding somatic cell reprogramming to iPSC, and could be targeted for inhibition or activation, in order to improve the process in canines. These results provide a vast resource for better understanding of pluripotency regulators in dogs and provide an unbiased rationale for novel canine-specific reprogramming approaches.

Identifiers

PMID33210453
PMCPMC7900587
OpenAlexW3101408804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.